NCT03685695View on ClinicalTrials.gov

Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

August 1, 2019

Study Completion Date

July 30, 2020

Conditions
Fallopian Tube Endometrioid TumorFallopian Tube Mucinous NeoplasmFallopian Tube Serous NeoplasmOvarian Clear Cell TumorOvarian Endometrioid TumorOvarian Mucinous TumorOvarian Serous TumorRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

DEVICE

Monitoring Device

Wear Fitbit Charge 2

OTHER

Physical Activity

Complete aimed walking steps

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT03685695 - Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | Biotech Hunter | Biotech Hunter